Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06159634

Comparison of the Efficacy of Using a Traction Device in Colonic Endoscopic Submucosal Dissection Versus Conventional ESD: A Randomized Clinical Trial

Led by Baylor College of Medicine · Updated on 2026-03-24

150

Participants Needed

2

Research Sites

7 weeks

Total Duration

On this page

Sponsors

B

Baylor College of Medicine

Lead Sponsor

M

Micro-Tech Endoscopy USA

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating the use of a traction device in colonic endoscopic submucosal dissection (ESD) compared to conventional ESD without traction. This study focuses on patients with complex colorectal polyps, particularly those with risks of superficial submucosal invasion. The investigation aims to determine whether the traction device can help speed up the ESD procedure and improve clinical outcomes, addressing challenges posed by the thin colon wall and difficult lesion locations. The trial is a prospective, randomized, controlled study conducted at Baylor St. Luke's Medical Center. Participants will be randomly assigned to one of two groups. One group will receive ESD with the assistance of a traction device called the Sure trac system, which includes a silicone band and a clip to apply traction, designed to facilitate the dissection process. The other group will undergo standard ESD without any traction device. Both procedures involve removing target colonic lesions using endoscopic submucosal dissection techniques. The study compares the effectiveness and safety of these approaches. During the procedure day, researchers will measure the speed of dissection, total procedure time, and rates of complete lesion removal. They will also monitor for adverse events during and up to 48 hours after the procedure, as well as one month afterward. Abdominal pain will be assessed one hour and 24 hours post-procedure. Participants will undergo these evaluations as part of the study, which continues until February 2027 to collect and analyze these clinical outcomes.

CONDITIONS

Brief Title

Traction vs. No Traction in Colonic ESD

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient is 18 years old or older.
  • Able to provide informed consent.
  • Referred for ESD procedure of colonic neoplastic lesions with at least one of the following: prior resection or scar of any size, granular lateral spreading tumors larger than 3 cm, non-granular lateral spreading tumors larger than 20 mm, or suspected submucosal invasion such as Paris classification II a +II or positive non-lifting sign.
Not Eligible

You will not qualify if you...

  • Patient is younger than 18 years old.
  • Unable or unwilling to provide consent.
  • Pregnant woman.
  • Lesions with pedunculated morphology (Paris IP, Ips).
  • Lesions located at the appendiceal orifice or ileocecal valve.
  • Lesions previously removed by other techniques besides ESD, such as hybrid ESD or submucosal tunneling (STER) and EMR.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Day 1 (procedure day)

Participants undergo endoscopic submucosal dissection (ESD) of colonic lesions, either with the assistance of a traction device or using standard methods without traction.

1 procedure visit and up to 2 follow-up visits within 48 hours

Follow-up

Duration - 1 month post-procedure

Participants are monitored for post-procedural adverse events and abdominal pain after the ESD procedure.

Approximately 2 visits (1 hour and 24 hours post-procedure) and 1 visit at 1 month

Trial Site Locations

Total: 2 locations

1

Baylor College of Medicine

Houston, Texas, United States, 77030

Actively Recruiting

2

Baylor St. Lukes Medical Center (BSLMC)

Houston, Texas, United States, 77030

Actively Recruiting

Loading map...

Research Team

M

Mai Khalaf, MD

M

Michael Mercado, BS

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

2

Similar Trials

Artificial Intelligence for Onsite Cytology Evaluation in En...

Gastrointestinal Neoplasm

Actively Recruiting

1 location

Prospective Single Centre, Post Market, Randomized Controlle...

Gastrointestinal Neoplasm

Actively Recruiting

2 locations

ctDNA Guided Palliative Systemic Therapy Compared to Standar...

Gastrointestinal Neoplasm

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Double-balloon endolumenal intervention platform with flexible grasper to expedite colonic endoscopic submucosal dissection.

Mohamed O Othman, Salmaan A Jawaid, Manav Rungta...

https://pubmed.ncbi.nlm.nih.gov/33738368

Efficacy of a Traction Device for Endoscopic Submucosal Dissection Using a Scissor-Type Knife: A Randomized Controlled Trial.

Yuzuru Tamaru, Toshio Kuwai, Akihiro Miyakawa...

https://pubmed.ncbi.nlm.nih.gov/36191269

Deep mural injury and perforation after colonic endoscopic mucosal resection: a new classification and analysis of risk factors.

Nicholas G Burgess, Milan S Bassan, Duncan McLeod...

https://pubmed.ncbi.nlm.nih.gov/27464708